Joshua Cohen sold $3.0M of Amylyx Pharmaceuticals stock
By AlphaYouPublished Form 4
Cohen Joshua B
Reporting filer
Joshua Cohen reported selling 100,000 shares of Amylyx Pharmaceuticals, Inc. for about $3.0M ($29.84 a share on average). Form 4 filed Nov 12, 2026 lists 2 entries.
See the price move since this trade →
- Disclosed
- Nov 12, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Cohen Joshua B | 2026-11-09 | S | Sale | 38105 | 29.3933 | 3,575,018 | 3 days | Filed terms
|
| Common Stock | Cohen Joshua B | 2026-11-09 | S | Sale | 61895 | 30.1098 | 3,513,123 | 3 days | Filed terms
|
Common Stock
- Owner
- Cohen Joshua B
- Date
- 2026-11-09
- Code
- S
- Action
- Sale
- Quantity
- 38105
- Price
- 29.3933
- Following holdings
- 3,575,018
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-09
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 38105
- transaction Price Per Share: 29.3933
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 3575018
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Cohen Joshua B
- Date
- 2026-11-09
- Code
- S
- Action
- Sale
- Quantity
- 61895
- Price
- 30.1098
- Following holdings
- 3,513,123
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-09
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 61895
- transaction Price Per Share: 30.1098
- id: F3
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 3513123
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Cohen Joshua B: Co-Chief Executive Officer, Director.
- The filing reports a Rule 10b5-1 trading plan.
- F1: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2026.
- F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.74 to $29.73. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.74 to $30.29. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Original sources
Prepared automatically from public filing data. Report a correction.